How Does the Mounjaro Patient Access Program Work?

What the Mounjaro Patient Access Program Actually Is

The Mounjaro Patient Access Program is a manufacturer-sponsored copay assistance card issued by Eli Lilly. It is not an insurance plan, a prior-authorization service, or a government benefit. The card lowers the amount a commercially insured patient pays at the pharmacy counter for tirzepatide, often reducing a retail cost of $1,069 per month to $25 per 28-day fill.

Eli Lilly launched tirzepatide under the brand name Mounjaro after the FDA approved it on May 13, 2022, for glycemic control in adults with type 2 diabetes [1]. A separate formulation, Zepbound, received FDA approval on November 8, 2023, specifically for chronic weight management in adults with obesity or overweight plus at least one weight-related comorbidity [2]. The two brands share the same active molecule but carry distinct indication labels and separate savings programs.

The Clinical Case for Tirzepatide

Tirzepatide's dual mechanism targets both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors simultaneously. In the SURPASS-2 trial (N=1,879), tirzepatide 15 mg produced a mean HbA1c reduction of 2.46 percentage points and a mean body-weight reduction of 12.4 kg at 40 weeks versus semaglutide 1 mg [3]. Those results helped establish tirzepatide as one of the most effective agents in its class for metabolic disease.

For weight loss specifically, the SURMOUNT-1 trial (N=2,539) demonstrated that tirzepatide 15 mg produced a mean weight reduction of 22.5% from baseline at 72 weeks versus 2.4% with placebo (P<0.001) [4]. These data support why clinicians and telehealth platforms like Calibrate prescribe it as a primary therapy rather than a fallback option.

How the FDA Label Affects Program Access

Because the Mounjaro label is limited to type 2 diabetes, the Mounjaro Savings Card technically applies to diabetes diagnoses. Patients prescribed tirzepatide for weight loss under a telehealth platform will generally be directed toward the Zepbound savings card instead. Confusing the two programs is a common administrative error that results in a pharmacy rejection at the point of sale.

Step-by-Step Enrollment in the Mounjaro Savings Card

Enrollment is free and takes four to six minutes. No income documentation is required for the commercially insured pathway.

Step 1: Confirm Commercial Insurance Coverage

The savings card is restricted to patients with commercial (private) insurance. Patients enrolled in Medicare, Medicaid, CHIP, TRICARE, or any other federal or state government health program are explicitly excluded by the program terms. This restriction exists because federal anti-kickback statutes prohibit manufacturers from subsidizing copays for government-insured beneficiaries [5].

If your insurance card says "Medicare Advantage," you are still considered a Medicare beneficiary and are not eligible for the commercial savings card, even if a private insurer administers the plan.

Step 2: Obtain a Valid Prescription

A licensed prescriber must generate a prescription for Mounjaro that includes the correct diagnosis code. For the Mounjaro Savings Card to process cleanly, the prescription should carry a type 2 diabetes indication (ICD-10: E11.x). Telehealth platforms including Calibrate employ physicians licensed in the patient's state of residence who can issue this prescription electronically to any participating pharmacy.

The American Diabetes Association 2024 Standards of Care list tirzepatide as a preferred agent for patients with type 2 diabetes who need greater HbA1c reduction or significant weight loss as a co-goal of therapy [6]. That guideline endorsement makes prescribers comfortable issuing the prescription even in a telehealth context.

Step 3: Activate the Savings Card Online

Go to saveonmounjaro.com. Enter your name, date of birth, and zip code. The site generates a card number and a group/BIN/PCN string that the pharmacy enters during adjudication. Print the card, screenshot it, or have it texted to your phone. No activation fee applies.

Step 4: Present the Card at a Participating Pharmacy

Hand the card to the pharmacist before the prescription is processed. Major chain pharmacies (CVS, Walgreens, Rite Aid, Walmart, Costco) and most independent pharmacies in the United States accept the card. Specialty pharmacies that focus on compounding do not process standard manufacturer savings cards.

Step 5: Pay $25 at the Counter

For eligible commercially insured patients, the out-of-pocket amount should be $25 per 28-day supply. If the register shows a higher amount, the pharmacy may have processed the claim against your insurance only without applying the savings card. Ask the pharmacist to re-adjudicate with the BIN/PCN from the savings card layered on top of your primary insurance.

Who Qualifies and Who Does Not

Eligible Patients

• Adults aged 18 or older with a valid Mounjaro prescription
• Enrolled in a commercial health insurance plan (employer-sponsored, marketplace, or individual)
• Residing in the United States or its territories
• Not participating in any government-funded prescription assistance at the same time

Ineligible Patients

• Medicare beneficiaries (Parts A, B, C, or D), including Medicare Advantage
• Medicaid or CHIP enrollees
• Veterans receiving VA pharmacy benefits for this medication
• Patients in states where the card is prohibited by law (at time of writing, no U.S. State actively prohibits it, but terms can change)

The FDA's guidance on copay accumulator programs is relevant here: since 2021, some insurers run "accumulator adjustment programs" that prevent manufacturer card payments from counting toward your annual deductible [7]. Ask your insurer directly whether your plan uses an accumulator. If it does, you may still pay $25 per fill, but the card payments will not reduce your deductible balance, extending the time before your insurance starts covering the drug at a higher level.

What Uninsured or Underinsured Patients Can Do

Patients without commercial insurance have fewer options, but several paths exist.

LillyConnect and Patient Support Programs

Eli Lilly operates LillyConnect, a patient support platform that can assess eligibility for free or reduced-cost medication through the Lilly Cares Foundation [8]. Income thresholds and asset tests apply. Processing typically takes two to four weeks, which creates a gap period.

GoodRx and Discount Cards

GoodRx and similar discount services can reduce the retail price of Mounjaro at certain pharmacies, though the resulting price is still substantially above the $25 savings-card amount. GoodRx prices for tirzepatide have ranged from $850 to $980 per month depending on the pharmacy and geographic market, based on publicly available pricing data as of early 2025.

Compounded Tirzepatide: A Regulatory Caution

During the FDA drug shortage period, compounding pharmacies filled tirzepatide under a shortage exemption. The FDA removed tirzepatide from its shortage list in October 2024 [9]. As a result, most compounding pharmacies are no longer permitted to produce copies of the branded product. Patients who received compounded tirzepatide should discuss transition to branded Mounjaro or Zepbound with their prescriber, since compounded versions are not FDA-approved and lack the bioequivalence data that branded products carry [10].

How Calibrate Interacts With the Mounjaro Patient Access Program

Calibrate is a telehealth metabolic health program that pairs GLP-1 or dual GIP/GLP-1 prescriptions with lifestyle coaching. Its model involves monthly coaching sessions, food and activity coaching, and physician oversight, with prescriptions sent to partner pharmacies or the patient's preferred local pharmacy.

How Calibrate's Prescription Workflow Affects Savings Card Use

Calibrate's physicians can prescribe tirzepatide under either the Mounjaro or Zepbound label depending on the patient's primary diagnosis. When the prescription goes to a retail pharmacy, the patient can present the appropriate savings card (Mounjaro card for type 2 diabetes diagnosis, Zepbound card for obesity diagnosis) independently of Calibrate's billing. Calibrate does not automatically apply the savings card; the patient must activate and present it separately.

Calibrate's Own Insurance Navigation

Calibrate has historically worked with certain insurers that cover GLP-1 medications with prior authorization. The company employs a team that assists with prior authorization letters and appeals. If insurance approves the claim fully, the manufacturer savings card is redundant (and should not be stacked on top of a $0 insurance copay, which violates the savings card terms).

Realistic Monthly Costs Through Calibrate Plus Savings Card

A Calibrate member with commercial insurance who uses the Mounjaro or Zepbound savings card should expect:

• Medication cost: $25 per 28-day fill (savings card rate)
• Calibrate program fee: variable by plan tier (ranges from $150 to $199 per month based on current published pricing)
• Total estimated monthly out-of-pocket: $175 to $224

Without the savings card, the medication alone could run $1,000 to $1,069 per month, making the card the single largest cost variable in the entire treatment equation.

Clinical Context: Why Tirzepatide's Cost Matters for Adherence

Medication cost is a documented predictor of adherence in chronic disease management. A 2023 analysis published in JAMA Internal Medicine found that high out-of-pocket costs for GLP-1 receptor agonists were associated with a 32% higher rate of early discontinuation compared with patients whose out-of-pocket costs were below $50 per month [11]. Tirzepatide requires continuous use to sustain weight loss; the SURMOUNT-4 trial (N=670) showed that patients who discontinued tirzepatide after a 36-week lead-in regained approximately two-thirds of their lost weight within 88 weeks [12].

These data underscore why navigating the savings program correctly is not a minor administrative task. Discontinuation because of cost can undo months of clinical progress.

Titration Schedule and How It Affects Your Fill Frequency

Tirzepatide starts at 2.5 mg once weekly and titrates upward in 2.5 mg increments every four weeks, per the FDA-approved prescribing information [13]. The titration schedule means the first fill at 2.5 mg covers four weeks, then a 5 mg fill covers the next four weeks, and so on. Each fill is a separate $25 transaction under the savings card. Budget for 12 fills per year regardless of dose level, as each fill contains four auto-injector pens (one per week).

Injection Technique and Storage: Adherence Basics

Proper technique reduces waste and side effects. Tirzepatide pens should be stored refrigerated at 36 to 46 degrees Fahrenheit until use [13]. A single pen can be kept at room temperature (below 86 degrees Fahrenheit) for up to 21 days. Injecting into a cold pen increases injection-site discomfort, which is a reported reason for missed doses in clinical practice. Allow the pen to reach room temperature for 30 minutes before injection.

The most common adverse effects reported in SURPASS-2 were nausea (17.6% with 15 mg), diarrhea (13.2%), and vomiting (9.8%), all of which were dose-dependent and generally transient [3]. Slow titration mitigates these effects.

Prior Authorization: The Step Before the Savings Card Matters

The savings card lowers your copay, but your insurance must first agree to cover the drug. Most commercial plans require prior authorization for tirzepatide, and many require step therapy (trying metformin and/or another agent first) [14].

What a Prior Authorization Letter Should Include

A well-written prior authorization letter for Mounjaro should include:

• Current HbA1c value and date of measurement
• Current diabetes medications and duration of use
• Documentation of inadequate glycemic control on current regimen
• BMI and relevant comorbidities
• The prescriber's clinical rationale for tirzepatide over alternatives

The American Association of Clinical Endocrinology (AACE) 2023 guidelines recommend a patient-centered approach to type 2 diabetes pharmacotherapy that accounts for weight, cardiovascular risk, and kidney function, and those guidelines specifically support the use of tirzepatide in appropriate patients [15]. Citing AACE 2023 in the prior authorization letter strengthens the clinical argument.

Appeals When Prior Authorization Is Denied

If your insurer denies the prior authorization, you have the right to appeal. The 2010 Affordable Care Act established federal appeal rights for most commercial plans, including a required external review process if the internal appeal fails [16]. Success rates for GLP-1 appeals are not uniformly published, but clinical documentation of diabetes control failure on prior agents is the single strongest predictor of approval reversal.

Comparing the Mounjaro Savings Card to the Zepbound Savings Card

| Feature | Mounjaro Savings Card | Zepbound Savings Card | |---|---|---| | Indication | Type 2 diabetes | Obesity / overweight with comorbidity | | Minimum copay (commercially insured) | $25 per fill | $25 per fill | | Maximum monthly savings | Up to $150 per fill | Up to $150 per fill | | Dose range covered | 2.5 to 15 mg | 2.5 to 15 mg | | Website | saveonmounjaro.com | saveonzepbound.com | | Medicare eligible | No | No | | Medicaid eligible | No | No |

Both cards are issued by Eli Lilly and share the same exclusion criteria. The choice between them depends entirely on the prescriber's diagnosis documentation, not on patient preference.

What to Do If the Savings Card Is Rejected at the Pharmacy

A rejection at the counter usually means one of five things:

1. The patient is enrolled in a government insurance program (ineligible).
2. The card was not activated before the pharmacist processed the claim.
3. The pharmacy entered the BIN/PCN incorrectly.
4. The patient's insurance uses an accumulator program that flags the claim.
5. The prescription diagnosis code does not match the savings card's indication.

Ask the pharmacist to reverse the transaction and re-process it with the savings card BIN/PCN as the primary payer (not a secondary). If the issue persists, call the number on the back of the savings card. Lilly's patient support line can often resolve adjudication errors in real time during the pharmacy visit.